Intern, Corporate Compliance

BioMarin Pharmaceutical Inc.

Mar 19

Applications are closed

Internship
Full-time
Summer Internship
Legal

Requirements

Preferred skills:
Excellent writing and research skills (writing sample required);
Proficiency with standard office technology and software, e.g. MS Office Suite, Outlook, etc.;
Strong communication, collaboration, problem-solving and time-management skills; and
Attention to detail; sense of humor; ability to work well independently and as part of a team.
Skills the intern will gain: The intern will gain exposure to healthcare compliance law, including FDCA, FCPA, FCA, AKS, data-privacy laws, and the Sunshine Act, and will gain skills including memo and policy drafting, gap analysis, and working on projects and communications to further Corporate Compliance’s goal of ensuring BioMarin remains compliant with all applicable laws.
Education: B.A./B.S. required, 1L law students preferred, 2L considered.
Work schedule: 40 hours per week
Other: Housing and transportation are the intern’s responsibility

Responsibilities

The successful applicant will provide support to the Corporate Compliance team, which is part of the larger Global Compliance & Ethics department.The intern will have the opportunity to support several cross-functional compliance activities, including promotional review activities, data privacy program, transparency reporting, corporate policy and procedure drafting and enforcement, enterprise risk assessment, and internal training and monitoring.The Corporate Compliance team works in close coordination with colleagues throughout the organization.The intern will assist Corporate Compliance staff members with day-to-day activities, including legal research, drafting memoranda, presenting findings, and other departmental projects.

BioMarin Pharmaceutical Inc.

We transform lives through genetic discovery.

Science & Healthcare

Industry

1001-5000

Employees

1997

Founded Year

Mission & Purpose

Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions that it seeks to treat, helping to better the lives of those struggling with rare genetic disease. BioMarin discoveries have led to eight first or best-in-class commercial treatments and a pipeline of multiple product candidates applying the same science-driven, patient-forward approach to broader group of genetic disorders. The more innovative solutions developed, the more lives BioMarin can impact.